Stock CPRX CATALYST PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Catalyst Pharmaceuticals, Inc.

Equities

CPRX

US14888U1016

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
14.89 USD +1.43% Intraday chart for Catalyst Pharmaceuticals, Inc. -1.59% -11.42%
04-10 Catalyst Pharmaceuticals Insider Sold Shares Worth $392,000, According to a Recent SEC Filing MT
04-04 Certain Stock Options of Catalyst Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 4-APR-2024. CI

Chart calendar Catalyst Pharmaceuticals, Inc.

490a866f541fcca3ab.ccSUkAugmMuweM86uSI8F3m2-CuJRyU568EHu4yvV8M.HPem_2HHzfmJOpt10xt-JhfAgEzEBHJOvKBpjuPAEPAok___W-LZqIgvqA~ff8da1d36f66198a719a890cec3b87a6

Upcoming events on Catalyst Pharmaceuticals, Inc.

07/05/2024 Q1 2024 Earnings Release After hours
09/05/2024 13:30 Q1 2024 Earnings Call
21/05/2024 14:00 Annual General Meeting
06/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
11/03/2025 Q4 2024 Earnings Release (Projected)
06/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Catalyst Pharmaceuticals, Inc.

02/04/2024 20:10 Cantor Fitzgerald Muscular Dystrophy Symposium
12/03/2024 17:35 Barclays Global Healthcare Conference
02/03/2024 Muscular Dystrophy Association Clinical & Scientific Conference - Poster Number: M174
29/02/2024 13:30 Q4 2023 Earnings Call
28/02/2024 23:03 Q4 2023 Earnings Release
29/11/2023 15:30 Piper Sandler Healthcare Conference
09/11/2023 13:30 Q3 2023 Earnings Call
08/11/2023 21:11 Q3 2023 Earnings Release
26/09/2023 16:05 Cantor Global Healthcare Conference
04/09/2023 14:00 International Epilepsy Congress - Poster number: P373
04/09/2023 13:30 International Epilepsy Congress - Poster number: P149
03/09/2023 15:30 International Epilepsy Congress - Oral Presentation number: 370
03/09/2023 14:00 International Epilepsy Congress - Poster number: P048
02/09/2023 14:00 International Epilepsy Congress - Poster number: P367
22/08/2023 14:00 Annual General Meeting
10/08/2023 13:30 Q2 2023 Earnings Call
09/08/2023 21:17 Q2 2023 Earnings Release
11/05/2023 13:30 Q1 2023 Earnings Call
10/05/2023 21:27 Q1 2023 Earnings Release
16/03/2023 12:30 Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		102
101
1.15%		119
118
0.84%		141
141
0.09%		214
214
-0.04%		398
394
1.18%
461

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
189

EBIT
Million USD		Released
Forecast
Spread 		31,8
35,0
-9.09%		41,3
43,1
-4.22%		52,4
55,2
-5.06%		102
101
1.15%		86,8
74,2
17.03%
176

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		33,4
36,6
-8.7%		41,9
43,8
-4.4%		52,7
55,6
-5.35%		105
102
2.5%		94,5
84,9
11.38%
184

Net income
Million USD		Released
Forecast
Spread 		31,9
34,8
-8.45%		75,0
73,0
2.68%		39,5
42,6
-7.42%		83,1
68,8
20.71%		71,4
67,0
6.61%
135

EPS
USD		Released
Forecast
Spread 		0,30
0,33
-9.09%		0,71
0,69
2.9%		0,37
0,40
-7.04%		0,75
0,73
2.18%		0,63
0,59
6.33%
1,13

Announcement Date16/03/2015/03/2116/03/2215/03/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		38,3
38,2
0.33%		43,1
42,8
0.78%		53,1
49,1
8.23%		57,2
53,7
6.61%		60,8
60,6
0.19%		85,4
81,6
4.59%		99,6
91,7
8.59%		103
100
2.31%		111
106
4.39%
98,8


112


121


129


125

EBITDA
Million USD		Released
Forecast
Spread



























49,8


60,8


56,1


54,4




EBIT
Million USD		Released
Forecast
Spread 		12,7
15,5
-17.98%		17,4
18,9
-8.25%		28,6
24,1
18.39%		29,2
27,0
7.98%		30,8
29,6
4.16%		35,6
47,8
-25.45%		46,7
36,6
27.68%		-37,2
-20,9
-77.57%		41,7
36,3
14.78%
31,5


43,3


48,6


52,7


44,5

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		12,8
15,8
-18.86%		17,5
19,1
-8.79%		28,2
24,3
16.29%		26,0
27,2
-4.32%		33,0
30,4
8.67%		37,3
47,8
-21.86%		48,5
37,9
27.9%		-38,0
-19,2
-97.82%		46,7
37,0
26.1%
35,1


45,1


50,0


54,2


46,9

Net income
Million USD		Released
Forecast
Spread 		9,31
12,5
-25.37%		13,2
14,7
-10.07%		21,6
18,2
18.83%		22,7
20,5
11.23%		25,5
19,9
27.87%		29,6
36,5
-18.99%		37,8
29,0
30.11%		-30,8
-20,0
-53.59%		34,8
30,4
14.58%
25,2


33,5


37,2


39,2


35,1

EPS
USD		Released
Forecast
Spread 		0,09
0,12
-22.41%		0,12
0,14
-11.76%		0,20
0,17
17.65%		0,20
0,19
5.26%		0,22
0,21
3.77%		0,26
0,32
-19.25%		0,33
0,25
29.92%		-0,29
-0,19
-52.63%		0,29
0,27
9.43%
0,21


0,28


0,31


0,32


0,28

Announcement Date16/03/2210/05/2209/08/2209/11/2215/03/2310/05/2309/08/2308/11/2328/02/24-----

Upcoming sector events for Catalyst Pharmaceuticals, Inc.

28/04/2024 HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release
28/04/2024 CANSINO BIOLOGICS INC.: Q1 2024 Earnings Release
28/04/2024 SHANGHAI JUNSHI BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release
28/04/2024 SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release (Projected)
29/04/2024 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.: Q1 2024 Earnings Release
29/04/2024 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release
29/04/2024 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release
29/04/2024 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release
30/04/2024 12:00 INCYTE CORPORATION: Q1 2024 Earnings Release
More events

Past sector events for Catalyst Pharmaceuticals, Inc.

26/04/2024 PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD: Q4 2023 Earnings Release
26/04/2024 BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.: Q1 2024 Earnings Release
26/04/2024 SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
26/04/2024 PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD: Q1 2024 Earnings Release
26/04/2024 TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
25/04/2024 SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
25/04/2024 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 LIAONING CHENGDA BIOTECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 HUALAN BIOLOGICAL VACCINE INC.: Q1 2024 Earnings Release
25/04/2024 HUALAN BIOLOGICAL ENGINEERING INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CPRX Stock
  4. Calendar Catalyst Pharmaceuticals, Inc.